Article | Published:

Cleavage of a carbon–fluorine bond by an engineered cysteine dioxygenase

Nature Chemical Biologyvolume 14pages853860 (2018) | Download Citation

Abstract

Cysteine dioxygenase (CDO) plays an essential role in sulfur metabolism by regulating homeostatic levels of cysteine. Human CDO contains a post-translationally generated Cys93–Tyr157 cross-linked cofactor. Here, we investigated this Cys–Tyr cross-linking by incorporating unnatural tyrosines in place of Tyr157 via a genetic method. The catalytically active variants were obtained with a thioether bond between Cys93 and the halogen-substituted Tyr157, and we determined the crystal structures of both wild-type and engineered CDO variants in the purely uncross-linked form and with a mature cofactor. Along with mass spectrometry and 19F NMR, these data indicated that the enzyme could catalyze oxidative C–F or C–Cl bond cleavage, resulting in a substantial conformational change of both Cys93 and Tyr157 during cofactor assembly. These findings provide insights into the mechanism of Cys–Tyr cofactor biogenesis and may aid the development of bioinspired aromatic carbon–halogen bond activation.

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

Additional information

Publisher’s note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

References

  1. 1.

    Walsh, C. T. Posttranslational Modification of Proteins: Expanding Nature’s Inventory. (Roberts & CompanyPublishers, Greenwood Village, CO, 2006).

  2. 2.

    Walsh, C. T., Garneau-Tsodikova, S. & Gatto, G. J. Jr. Protein posttranslational modifications: the chemistry of proteome diversifications. Angew. Chem. Int. Ed. Engl. 44, 7342–7372 (2005).

  3. 3.

    Klinman, J. P. & Bonnot, F. Intrigues and intricacies of the biosynthetic pathways for the enzymatic quinocofactors: PQQ, TTQ, CTQ, TPQ, and LTQ. Chem. Rev. 114, 4343–4365 (2014).

  4. 4.

    Stubbe, J. & van Der Donk, W. A. Protein radicals in enzyme catalysis. Chem. Rev. 98, 705–762 (1998).

  5. 5.

    Krebs, C., Bollinger, J. M. Jr. & Booker, S. J. Cyanobacterial alkane biosynthesis further expands the catalytic repertoire of the ferritin-like ‘di-iron-carboxylate’ proteins. Curr. Opin. Chem. Biol. 15, 291–303 (2011).

  6. 6.

    McCoy, J. G. et al. Structure and mechanism of mouse cysteine dioxygenase. Proc. Natl. Acad. Sci. USA 103, 3084–3089 (2006).

  7. 7.

    Simmons, C. R. et al. Crystal structure of mammalian cysteine dioxygenase. A novel mononuclear iron center for cysteine thiol oxidation. J. Biol. Chem. 281, 18723–18733 (2006).

  8. 8.

    Whittaker, J. W. Free radical catalysis by galactose oxidase. Chem. Rev. 103, 2347–2363 (2003).

  9. 9.

    Cowley, R. E. et al. Structure of the reduced copper active site in preprocessed galactose oxidase: ligand tuning for one-electron O2 activation in cofactor biogenesis. J. Am. Chem. Soc. 138, 13219–13229 (2016).

  10. 10.

    Schnell, R., Sandalova, T., Hellman, U., Lindqvist, Y. & Schneider, G. Siroheme- and [Fe4-S4]-dependent NirA from Mycobacterium tuberculosis is a sulfite reductase with a covalent Cys-Tyr bond in the active site. J. Biol. Chem. 280, 27319–27328 (2005).

  11. 11.

    Polyakov, K. M. et al. High-resolution structural analysis of a novel octaheme cytochrome c nitrite reductase from the haloalkaliphilic bacterium Thioalkalivibrio nitratireducens. J. Mol. Biol. 389, 846–862 (2009).

  12. 12.

    Hromada, S. E. et al. Protein oxidation involved in Cys-Tyr post-translational modification. J. Inorg. Biochem. 176, 168–174 (2017).

  13. 13.

    Stipanuk, M. H., Ueki, I., Dominy, J. E. Jr., Simmons, C. R. & Hirschberger, L. L. Cysteine dioxygenase: a robust system for regulation of cellular cysteine levels. Amino Acids 37, 55–63 (2009).

  14. 14.

    Ye, S. et al. An insight into the mechanism of human cysteine dioxygenase. Key roles of the thioether-bonded tyrosine-cysteine cofactor. J. Biol. Chem. 282, 3391–3402 (2007).

  15. 15.

    Dominy, J. E. Jr. et al. Synthesis of amino acid cofactor in cysteine dioxygenase is regulated by substrate and represents a novel post-translational regulation of activity. J. Biol. Chem. 283, 12188–12201 (2008).

  16. 16.

    Niewiadomski, J. et al. Effects of a block in cysteine catabolism on energy balance and fat metabolism in mice. Ann. NY Acad. Sci. 1363, 99–115 (2016).

  17. 17.

    Gordon, C., Bradley, H., Waring, R. H. & Emery, P. Abnormal sulphur oxidation in systemic lupus erythematosus. Lancet 339, 25–26 (1992).

  18. 18.

    Kwon, D. Y. et al. Impaired sulfur-amino acid metabolism and oxidative stress in nonalcoholic fatty liver are alleviated by betaine supplementation in rats. J. Nutr. 139, 63–68 (2009).

  19. 19.

    Olson, K. R. et al. Thiosulfate: a readily accessible source of hydrogen sulfide in oxygen sensing. Am. J. Physiol. Regul. Integr. Comp. Physiol. 305, R592–R603 (2013).

  20. 20.

    Weits, D. A. et al. Plant cysteine oxidases control the oxygen-dependent branch of the N-end-rule pathway. Nat. Commun. 5, 3425 (2014).

  21. 21.

    White, M. D. et al. Plant cysteine oxidases are dioxygenases that directly enable arginyl transferase-catalysed arginylation of N-end rule targets. Nat. Commun. 8, 14690 (2017).

  22. 22.

    Ueki, I. et al. Knockout of the murine cysteine dioxygenase gene results in severe impairment in ability to synthesize taurine and an increased catabolism of cysteine to hydrogen sulfide. Am. J. Physiol. Endocrinol. Metab. 301, E668–E684 (2011).

  23. 23.

    Bradley, H. et al. Sulfate metabolism is abnormal in patients with rheumatoid arthritis Confirmation by in vivo biochemical findings. J. Rheumatol. 21, 1192–1196 (1994).

  24. 24.

    Jeschke, J. et al. Frequent inactivation of cysteine dioxygenase type 1 contributes to survival of breast cancer cells and resistance to anthracyclines. Clin. Cancer Res. 19, 3201–3211 (2013).

  25. 25.

    Heafield, M. T. et al. Plasma cysteine and sulphate levels in patients with motor neurone, Parkinson’s and Alzheimer’s disease. Neurosci. Lett. 110, 216–220 (1990).

  26. 26.

    Li, W., Blaesi, E. J., Pecore, M. D., Crowell, J. K. & Pierce, B. S. Second-sphere interactions between the C93-Y157 cross-link and the substrate-bound Fe site influence the O2 coupling efficiency in mouse cysteine dioxygenase. Biochemistry 52, 9104–9119 (2013).

  27. 27.

    Davies, C. G., Fellner, M., Tchesnokov, E. P., Wilbanks, S. M. & Jameson, G. N. The Cys-Tyr cross-link of cysteine dioxygenase changes the optimal pH of the reaction without a structural change. Biochemistry 53, 7961–7968 (2014).

  28. 28.

    Driggers, C. M. et al. Structure-based insights into the role of the Cys-Tyr crosslink and inhibitor recognition by mammalian cysteine dioxygenase. J. Mol. Biol. 428, 3999–4012 (2016).

  29. 29.

    Wang, L., Brock, A., Herberich, B. & Schultz, P. G. Expanding the genetic code of Escherichia coli. Science 292, 498–500 (2001).

  30. 30.

    Driggers, C. M. et al. Cysteine dioxygenase structures from pH4 to 9: consistent cys-persulfenate formation at intermediate pH and a Cys-bound enzyme at higher pH. J. Mol. Biol. 425, 3121–3136 (2013).

  31. 31.

    Souness, R. J. et al. Mechanistic implications of persulfenate and persulfide binding in the active site of cysteine dioxygenase. Biochemistry 52, 7606–7617 (2013).

  32. 32.

    Tchesnokov, E. P. et al. An iron-oxygen intermediate formed during the catalytic cycle of cysteine dioxygenase. Chem. Commun. (Camb.) 52, 8814–8817 (2016).

  33. 33.

    Oyala, P. H. et al. Biophysical characterization of fluorotyrosine probes site-specifically incorporated into enzymes: E. coli ribonucleotide reductase as an example. J. Am. Chem. Soc. 138, 7951–7964 (2016).

  34. 34.

    Ravichandran, K. R. et al. Formal reduction potentials of difluorotyrosine and trifluorotyrosine protein residues: defining the thermodynamics of multistep radical transfer. J. Am. Chem. Soc. 139, 2994–3004 (2017).

  35. 35.

    Minnihan, E. C., Young, D. D., Schultz, P. G. & Stubbe, J. Incorporation of fluorotyrosines into ribonucleotide reductase using an evolved, polyspecific aminoacyl-tRNA synthetase. J. Am. Chem. Soc. 133, 15942–15945 (2011).

  36. 36.

    Li, F. et al. A genetically encoded 19F NMR probe for tyrosine phosphorylation. Angew. Chem. Int. Edn Engl. 52, 3958–3962 (2013).

  37. 37.

    Liu, X. et al. Significant expansion of fluorescent protein sensing ability through the genetic incorporation of superior photo-induced electron-transfer quenchers. J. Am. Chem. Soc. 136, 13094–13097 (2014).

  38. 38.

    O’Hagan, D. Understanding organofluorine chemistry. An introduction to the C-F bond. Chem. Soc. Rev. 37, 308–319 (2008).

  39. 39.

    Suckau, D. et al. A novel MALDI LIFT-TOF/TOF mass spectrometer for proteomics. Anal. Bioanal. Chem. 376, 952–965 (2003).

  40. 40.

    Fellner, M., Aloi, S., Tchesnokov, E. P., Wilbanks, S. M. & Jameson, G. N. Substrate and pH-dependent kinetic profile of 3-mercaptopropionate dioxygenase from Pseudomonas aeruginosa. Biochemistry 55, 1362–1371 (2016).

  41. 41.

    Cottrell, T.L. The Strengths of Chemical Bonds. 2nd edn. (Butterworths Scientific, 1958).

  42. 42.

    Sahu, S. et al. Aromatic C-F hydroxylation by nonheme iron(IV)-oxo complexes: Structural, spectroscopic, and mechanistic Investigations. J. Am. Chem. Soc. 138, 12791–12802 (2016).

  43. 43.

    Sahu, S. et al. Direct observation of a nonheme iron(IV)-oxo complex that mediates aromatic C-F hydroxylation. J. Am. Chem. Soc. 136, 13542–13545 (2014).

  44. 44.

    Chan, P. W. Y., Yakunin, A. F., Edwards, E. A. & Pai, E. F. Mapping the reaction coordinates of enzymatic defluorination. J. Am. Chem. Soc. 133, 7461–7468 (2011).

  45. 45.

    Tiedt, O. et al. ATP-dependent C-F bond cleavage allows the complete degradation of 4-fluoroaromatics without oxygen. MBio 7, e00990–16 (2016).

  46. 46.

    Seyedsayamdost, M. R., Yee, C. S. & Stubbe, J. Site-specific incorporation of fluorotyrosines into the R2 subunit of E. coli ribonucleotide reductase by expressed protein ligation. Nat. Protoc. 2, 1225–1235 (2007).

  47. 47.

    Arjune, S., Schwarz, G. & Belaidi, A. A. Involvement of the Cys-Tyr cofactor on iron binding in the active site of human cysteine dioxygenase. Amino Acids 47, 55–63 (2015).

  48. 48.

    Stipanuk, M. H., Dominy, J. E. Jr., Ueki, I. & Hirschberger, L. L. Measurement of cysteine dioxygenase activity and protein abundance. Curr. Protoc. Toxicol. 38, 6.15.11–16.15.25 (2008).

  49. 49.

    Otwinowski, Z. & Minor, W. Processing of X-ray diffraction data collected in oscillation mode. Methods Enzymol. 276, 307–326 (1997).

  50. 50.

    Adams, P. D. et al. PHENIX: a comprehensive Python-based system for macromolecular structure solution. Acta Crystallogr. D Biol. Crystallogr. 66, (213–221 (2010).

  51. 51.

    Emsley, P. & Cowtan, K. Coot: model-building tools for molecular graphics. Acta Crystallogr. D Biol. Crystallogr. 60, 2126–2132 (2004).

  52. 52.

    Kleffmann, T., Jongkees, S. A. K., Fairweather, G., Wilbanks, S. M. & Jameson, G. N. L. Mass-spectrometric characterization of two posttranslational modifications of cysteine dioxygenase. J. Biol. Inorg. Chem. 14, 913–921 (2009).

Download references

Acknowledgements

The work is supported in part by the National Institutes of Health grants GM107529, GM108988, and MH107985, the National Science Foundation grant CHE-1623856, and the Lutcher Brown Distinguished Chair Endowment fund (to A.L.). J.W. acknowledges the support of the National Science Foundation of China grants (91527302, 31370016, and U1532150). The mass spectrometry facility is sponsored by the National Institutes of Health grant G12MD007591. The MALDI-TOF and NMR spectrometers are shared instruments sponsored by the National Science Foundation under the award numbers #1126708 and 1625963, respectively. X-ray synchrotron data were collected at the beamlines of the Advanced Photon Source Section 19, Structural Biology Center user program GUP-48198, Argonne National Laboratory and at the beamline BL9-2 of the Stanford Synchrotron Radiation Lightsource (SSRL) under the user program #5B14, SLAC National Accelerator Laboratory. The beamline staff scientists are acknowledged for the assistance of the remote data collections. The Advanced Photon Source is a US Department of Energy, Office of Science User Facility operated for the DOE Office of Science by Argonne National Laboratory under Contract No. DE-AC02-06CH11357. SSRL is supported by the US Department of Energy, Office of Science, Office of Basic Energy Sciences under Contract No. DE-AC02-76SF00515 and by the National Institutes of Health (P41GM103393). The contents of this publication are solely the responsibility of the authors and do not necessarily represent the official views of National Institutes of Health or National Science Foundation.

Author information

Affiliations

  1. Department of Chemistry, University of Texas at San Antonio, San Antonio, TX, USA

    • Jiasong Li
    • , Wendell P. Griffith
    • , Ian Davis
    • , Inchul Shin
    • , Yifan Wang
    • , Daniel J. Wherritt
    •  & Aimin Liu
  2. Institute of Biophysics, Chinese Academy of Sciences, Beijing, P.R. China

    • Jiangyun Wang
    •  & Fahui Li

Authors

  1. Search for Jiasong Li in:

  2. Search for Wendell P. Griffith in:

  3. Search for Ian Davis in:

  4. Search for Inchul Shin in:

  5. Search for Jiangyun Wang in:

  6. Search for Fahui Li in:

  7. Search for Yifan Wang in:

  8. Search for Daniel J. Wherritt in:

  9. Search for Aimin Liu in:

Contributions

Genetic incorporation of unnatural amino acids was performed by J.L. (cloning, protein expression and purification, and enzyme assays). J.W. and F.L. provided TyrRS. W.P.G. and J.L. conducted mass spectrometry analyses. J.L. obtained all protein crystals, collected X-ray diffraction data, and interpreted and refined the structural data together with I.S. The mechanistic models were proposed and refined by J.L., I.D., Y.W., and A.L. Y.W. participated in the unnatural amino acid production and isolation by an enzymatic method. D.J.W. performed the 19F NMR analysis. A.L. conceived the research and wrote the manuscript together with J.L. All authors contributed to data analysis and to the writing and editing of the manuscript.

Competing interests

The authors declare no competing interests.

Corresponding author

Correspondence to Aimin Liu.

Supplementary information

  1. Supplementary Text and Figures

    Supplementary Tables 1–2, Supplementary Figures 1–11

  2. Reporting Summary

About this article

Publication history

Received

Accepted

Published

DOI

https://doi.org/10.1038/s41589-018-0085-5